Caricamento...
Diabetes and gout: efficacy and safety of febuxostat and allopurinol
Aim Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. Methods Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month rando...
Salvato in:
Autori principali: | , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Blackwell Publishing Ltd
2013
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902994/ https://ncbi.nlm.nih.gov/pubmed/23683134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12135 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|